Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature
R Jones III, DJ Rhee - Current opinion in ophthalmology, 2006 - journals.lww.com
R Jones III, DJ Rhee
Current opinion in ophthalmology, 2006•journals.lww.comCorticosteroid-induced ocular hypertension and glaucoma has been recognized for more
than 50 years. Knowing the risk factors, prevalence, and pathophysiology can help the
clinician prevent, monitor, and treat corticosteroid-induced ocular hypertension and
glaucoma. Abbreviations: ECM, extracellular matrix; IOP, intraocular pressure; IVTA,
intravitreal triamcinolone acetonide; POAG, primary open-angle glaucoma
than 50 years. Knowing the risk factors, prevalence, and pathophysiology can help the
clinician prevent, monitor, and treat corticosteroid-induced ocular hypertension and
glaucoma. Abbreviations: ECM, extracellular matrix; IOP, intraocular pressure; IVTA,
intravitreal triamcinolone acetonide; POAG, primary open-angle glaucoma
Summary
Corticosteroid-induced ocular hypertension and glaucoma has been recognized for more than 50 years. Knowing the risk factors, prevalence, and pathophysiology can help the clinician prevent, monitor, and treat corticosteroid-induced ocular hypertension and glaucoma.
Abbreviations: ECM, extracellular matrix; IOP, intraocular pressure; IVTA, intravitreal triamcinolone acetonide; POAG, primary open-angle glaucoma
Lippincott Williams & Wilkins